1. Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial. Issue 2 (2nd October 2008) Authors: Kruis, W; Kiudelis, G; Rácz, I; Gorelov, I A; Pokrotnieks, J; Horynski, M; Batovsky, M; Kykal, J; Boehm, S; Greinwald, R; Mueller, R Journal: Gut Issue: Volume 58:Issue 2(2009) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P752 Oral once daily budesonide granules rapidly induce clinical remission in Lymphocytic Colitis: A double-blind, double-dummy, multi-centre, randomised trial. (16th January 2018) Authors: Miehlke, S; Aust, D; Mihaly, E; Armerding, P; Böhm, G; Bonderup, O; Fernández-Bañares, F; Kupcinskas, J; Munck, L K; Rehbehn, K -U; Nacak, T; Greinwald, R; Münch, A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗